Flu Vaccine, Even with Infection, Reduces Risk of Heart Attack and Stroke

The Statens Serum Institut in Copenhagen found that flu vaccines may protect against heart attack and stroke, even if the flu is still developed after vaccination.

FDA Approves Drug to Treat Hunter Syndrome

Avlayah (tividenofusp alfa-eknm) has been FDA-approved to treat some individuals with Hunter Syndrome (Mucopolysaccharidosis type II or MPS II).

Pain-Relieving Drug with Minimal Addictive Properties Discovered

The novel opioid DFNZ shows potential for pain and opioid use disorder without causing depressed breathing.

Study Finds Connection with Inflammation in Autoimmune Diseases and Cancer Risk

Immune-mediated inflammatory disease (IMID) patients have been found to have a high risk of developing cancer, but that risk declines as inflammation decreases.

FDA Approves Veligrotug-vvze (Lumvoa) for Thyroid Eye Disease

The U.S. Food and Drug Administration has approved veligrotug-vvze (Lumvoa; Viridian Therapeutics) to treat thyroid eye disease.

FDA Approves Moderna’s mRNA Influenza Vaccine

The U.S. Food and Drug Administration’s accines and Related Biological Products Advisory Committee voted to recommend approval of the Moderna’s investigational mRNA influenza vaccine, which will be marketed under the brand name mFlusiva, for the prevention of flu in adults age 50 to 64.

COVID-19 and Influenza Coadministered Vaccines May Loiwer Risk of MACE in Older Adults

According to a recent study, coadministration of the COVID-19 vaccine with the annual influenza vaccine may reduce COVID-19-related major adverse cardiovascular events (MACE) among older adults, especially those with comorbidities. In the study, researchers conducted a target trial emulation using electronic health record data of more than one million veterans (mean age, 70 years; 92 […]

COVID-19 Vaccines Lower Risk of Heart Attack and Cardiac Death

ccording to three different studies, COVID-19 vaccines were associated with a lower risk of major adverse cardiovascular events (MACE), in addition to other outcomes, particularly among older adults.

Shingles Vaccine Reduces Risk of a Dementia Diagnosis

According to a cohort study using target trial emulation, older adults at higher risk for dementia are less likely to have a dementia diagnosis if they received a herpes zoster (shingles) vaccine.

IVIG Reduces Grade 2 Infections by 67 Percent in CLL

A study has found that intravenous immune globulin (IVIG) reduces grade 2 infections by 67 percent in patients with chronic lymphocytic leukemia.